Imaging errors in localization of COMS-type plaques in choroidal melanoma brachytherapy.

نویسندگان

  • Mahdi Bayat
  • Azra Alizad
  • Rachel Tamminga
  • Jose S Pulido
  • Mostafa Fatemi
چکیده

PURPOSE To investigate mathematically and experimentally the sources of errors in localization of COMS-type plaques in melanoma brachytherapy when using ultrasound and transillumination and to give recommendations to avoid such errors. METHODS A computer-aided simulation tool was developed to model the errors seen in the patient images when using ultrasound imaging and transillumination during localization of the COMS-type plaque in melanoma brachytherapy. Several laboratory experiments were performed on sheep eyes to confirm the validity of the error sources and the simulator outputs. Results were compared to the intraoperative ultrasonographic patient images for validation. RESULTS Based on mathematical modeling and computer simulation results, transillumination provides acceptable accuracy for small to medium tumors with less than 7-mm height but shows poor accuracy as the tumor height increases. In ultrasound imaging, two sources of error are predicted in longitudinal scan using our computer simulation modeling, and the results are supported by the experiments on sheep eyes and patient images taken during the operation. Both errors are related to the lens. The first error is due to attenuation and refraction of the lens causing opaque areas and a change of curvature in the image of the plaque edge that is nearest to the lens. The second type of error is related to the total internal reflection from the lens. CONCLUSIONS The simulation method presented in this article allows quantitative assessment of the sources, mechanisms, and measures of errors in localization of the CMOS-type plaques by ultrasound and transillumination techniques. Errors predicted by the simulation method are validated by experiments. Error assessment by this method provides guidelines for avoiding such errors.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.

PURPOSE The Collaborative Ocular Melanoma Study (COMS) established iodine-125 (I-125) plaque brachytherapy for eye preserving treatment of medium-sized choroidal melanomas in the United States. Eye Physics I-125 plaque treatment modeled with Plaque Simulator (PS) software yields similar results to COMS. Herein, we report results from a series of 15 patients treated with ruthenium-106 (Ru-106) p...

متن کامل

Dosimetry Comparison of Water Phantom and Complete Eye Definition for 125I and 103Pd Brachytherapy Plaques

Introduction: In this paper, by complete definition of human eye containing the various parts and their materials, the difference between this model and a homogeneous water phantom are compared for two ophthalmic plaques using 125I and 103Pd. Material and methods: The simulation of the two phantoms were performed in the MCNP-4C code and by using the geometry of a three-dimensional eye, differen...

متن کامل

The Collaborative Ocular Melanoma Study: an overview.

BACKGROUND The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal melanomas, and the effectiveness of enucleation with and without preoperative external-beam radiotherapy for large choroidal melanomas. The third arm is an ...

متن کامل

The investigators' perspective on the collaborative ocular melanoma study.

bling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107(8):1443-1449. 8. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2106. 9. Presch...

متن کامل

Uveal Melanoma Research and Treatment at Mayo Clinic

Mayo Clinic in Rochester, Minnesota, has a long history in the treatment of uveal melanomas. In the early 1980s, Dennis Robertson, MD, was one of the first to use iodine-125 plaques, the form of brachytherapy most commonly used for treatment of uveal melanomas in the United States today. The plaques used in the Collaborative Ocular Melanoma Study (COMS), a multicenter study initiated in 1985 to...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Investigative ophthalmology & visual science

دوره 54 10  شماره 

صفحات  -

تاریخ انتشار 2013